FDA Approves RINGERS — ICU Medical, Inc.
# FDA Approves ICU Medical's Lactated Ringer's Solution, Expanding Critical Care Portfolio ICU Medical, Inc. has received FDA approval for Ringers (sodium chloride, potassium chloride, and calcium chloride) intravenous solution, a balanced electrolyte formulation expected to strengthen the company's position in the high-volume hospital and acute care markets. The approval of this essential crystalloid fluid positions ICU Medical to capture significant market share in intravenous therapy, a foundational category in critical care and surgical settings.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day